2011 Analytical Chemistry Clinical Development Trials 
Drug Discovery World
MARCH 7, 2023
Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialisation, and at Georgetown Law School as an adjunct professor.
The Pharma Data
NOVEMBER 5, 2020
Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. O’Day has been a principal investigator for more than 200 clinical trials.
Expert insights. Personalized for you.
246 
Let's personalize your content